Zymergen Raises $400 Million in Landmark Agtech Deal

Washington, DC – January 3, 2019 – Cooley advised Zymergen on patent prosecution and IP diligence matters surrounding its $400 million Series C funding led by returning investor SoftBank Vision Fund. The deal is the largest round of funding for a US-based startup operating upstream in the food and agriculture supply chain. Cooley lawyers Erich Veitenheimer and Chris Holly headed the team advising Zymergen.

Zymergen is the world’s first molecular manufacturing technology company, developing molecules used in industries including agriculture, chemicals, materials, pharmaceuticals, electronics and more.

Cooley’s patent team advises Zymergen on all aspects of IP matters, including the company’s foundational high-throughput genomic engineering platform.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,000+ lawyers across 13 offices in the United States, China and Europe.

Related Contacts
Erich Veitenheimer  Senior Counsel Washington, DC
Chris Holly  Partner Washington, DC
Marcelo Pomeranz  Associate Washington, DC
Catherine Cowley  Special Counsel London
Jong-Jin (JJ) Han  Patent Agent Washington, DC
Michael McEvoy  Patent Agent Washington, DC
Jordan Phelan  Patent Agent Washington, DC
Jeffery Wyzykowski  Patent Agent Washington, DC